gested, and the idea has gained almost universal support, that so-called 'undifferentiated connective tissue cells' or 'primitive mesenchymal cells', can in certain circumstances be induced to become osteoblasts by a process akin to that which takes place during embryonic development. The most thorough investigations, utilizing bone treated in various ways and transplanted into soft tissues, have suggested that the hypothetical 'inducer' is a part of the organic component of preformed bone (Urist et al. 1967 , Burwell 1966 .
The spontaneous growth of bone inside an implant of polyHEMA sponge, in the skin, by a process of intramembranous ossification, demonstrates conclusively that in this case the initiation of heterotopic ossification does not depend on the presence of preformed organic or inorganic components of the skeleton, or its cells. This interesting phenomenon requires further analysis, but meanwhile it may be pointed out that in the sponge the deposition of calcium phosphate mineral very clearly precedes ossification. The same is true of endochondral ossification and of bone formation in the ischwmic kidney and some other examples of heterotopic bone formation. As a working hypothesis, therefore, it is postulated that insoluble calcium salt is the moderator which determines that the newly formed connective tissue cells, originating most likely from mononuclear cells brought to the site in the blood vessels, shall proceed to manufacture bone. It is probable that other local factors, including mechanical ones, are important in determining the kind of connective tissue that will be formed. In 1952, J S Barr of Boston, in his Presidential Address to the American Academy of Orthopedic Surgeons, condemned the present order whereby materials are used clinically and only investigated when things go wrong. Indeed he went further, stating that 'scientific testing methods are available which are much more accurate than clinical trial and the human guineapig technique is to a large extent outmoded and indefensible'.
In that same year a young woman had bilateral implants for breast hypoplasia, for which she was charged £200. Twelve years later I removed both at her urgent request, and on examination found that they were cellophane bags stuffed with shredded cellophane strips to retain bulk. This case is unusual, not because of the nature of the material used for restoration of contour, but because this highly unsuitable material had been retained by the body for such a long period. No doubt the surgeon responsible considered her his most successful case, for the number of 'successes' from such treatment must have been quite small.
In 1963 I published the results of two years' work on the then available materials used for reconstructive surgery. At the time it was noted that of the 38 reports published between 1953 and 1963, promoting the clinical use of one material or another, only 10 recorded any microscopic findings of the implants and only 4 mentioned experimental laboratory investigations. This is just not good enough. Unfortunately things have not improved in the past five years, and I suggest we start 1970 with at least three resolutions: (1) To discontinue the practice of purchasing our implant materials from the supermarket. (2) To define what kind of material we want for a particular purpose. (3) To publish the laboratory and clinical experience for any one material, and to review the situation at intervals thereafter.
Our surgical literature abounds with commendations for materials which today no one uses. You will search in vain for reports of the failure of these materials. This is neither scientific nor honest, and if we do not put our house in order someone else will. Indeed the Safety of Drugs Committee now expects to be informed of the clinical use of any new implant material even though this is not strictly a drug by definition, and this Committee is likely to lay down specific safeguards in the future..
What have we learned so far?
Needfor Foreign Implants in Reconstruction
In 1953 there was a sizable body of opinion against the use of any material in reconstruction which was not the patient's own tissue. The opposition to foreign implants has diminished because of the advantages: (1) Reconstruction is easier, shorter and less traumatic for the patient. (2) There is an unlimited supply. (3) Some natural tissues do not transplant well: fat absorbs, tendons become adherent, cartilage warps or absorbs, and bone may absorb at certain sites. (4) Some natural tissues are in short supply, such as tendon with paratenon; in certain patients the amount of available subcutaneous fat may be far short of that required for the restoration of contour. (5) In children there is an advantage in using an expendable material during a period of growth, even though the final and definitive procedure may use natural tissues.
Tissue Reactions
The tissue reactions to implants can be classified according to the properties of the materials used: Chemical: Acute or chronic inflammation due to the chemical nature ofthe implant material. Many of the plastic materials used twenty years ago evoked chemical reactions which required their removal. Today some stainless steels used in hip reconstruction do the same: the studies of Scales (1969, personal communication) and Freeman et al. (1969) on the mobilization of nickel from metals are important. Physical: The chemical irritants in implants were recognized some years ago when people began to talk about 'inert' materials, but the tissue reactions to the purely physical form of the implant were not appreciated. Hence polytetrafluoroethylene (Teflon) was hailed as an inert material, which it was, and when implanted in sheet form the body produced a thin fibrous cap- Fig 1. A, note marked ingrowth of collagen, cellular reaction and large blood spaces. H& E. x 25. B, showinggiant cells surrounding loose fibres ofthePTFE. x 60 sule around it (Fig 1) . This was interpreted as 'acceptance' of the implant. However, when the same material was implanted as a woven cloth or as felt, the fibrous capsule was less quiet or continuous around it, giant cells w-ere present even months later, and large blood spaces not lined by endothelium were found throughout ( Fig  2) . This latter reaction cannot in any sense be considered as 'acceptance.' Biological: In addition to the two types of reaction already mentioned, there is a third or 'biological' reaction which at the moment is ill-defined. Tissue reaction to the trauma of inisertion of an implant can be recognized and is expected to subside in a matter of weeks. However, there must be some recognition by the body that the material is 'foreign', and this may evoke collections of specialized cells at its periphery.
Alternatively, one can view the tissue reactions to implants on a purely pathological basis: Acute: Evoking round cells, polymorphs and many new blood vessels.
Chronic: Round cells, giant cells, blood spaces and perhaps encapsulation. Acceptance: But we must define what we mean by this. Infection: Either immediate, or late because the potential for resistance to infection is reduced.
Neoplastic: Neoplasia appears to occur in rats irrespective of the nature of the implant (Oppenheimer et al. 1955) but the incidence in other rodents is low. There is no good evidence of neoplastic changes directly due to implants occurring in man, but this may merely mean that the period of observation has been too short.
It is quite clear that we have to lay down in more precise terms what is required from any particular implant, and then to request the plastic chemist to produce the material. I shall discuss only one aspect, restoration of contour, to avoid confusion in objectives.
Methods ofLaboratory Testing
So far much of what I have said has been theoretical, and we must admit that the methods available for biological testing of materials are limited.
Materials have been implanted subcutaneously, intraperitoneally and intravascularly in rats, rabbits, pigs and dogs, and examined at intervals thereafter. Four methods of examination have been used to provide information on the tissue reactions. Histological sections will identify the gross chemical and physical reactions. Injection of vessels into the area of the implant allows assessment of the vascular supply. Sampling of fluid from around and within the implant provides information on the fluid environment of the material and, lastly, the clearance of isotopelabelled natural substances indicates the speed and nature of the dynamic fluid exchange.
Materialfor Contour Restoration
For restoration of bulk, the type oftissue reaction which I would like to find would be: A thin capsule around the material, to hold it at the site of insertion; the capsule, however, should be well vascularized (Fig 3) . Tissue cells freely mobile within the material. Correct fluid environment around and within the implant. An adequate blood supply, around and within the material.
The material itself should be rather soft, and easily shaped at the time of insertion, should have a low source of energy, should either degrade into a known body constituent or show no alteration in vivo, and should be inert chemically and physically.
What I do not want to see are: A thick fibrous avascular capsule around the implant (Fig 4) . Giant cells or other collections of cells. A high source of inherent energy in the material. No fluid exchange betweenthe implant and the bodytissues.
If all these tests indicate that the material is likely to be useful clinically, then a limited trial in man, using similar methods of assessment, seems justified. Only when this, too, has been done should a controlled clinical trial be entertained.
The Implant Environment
Little has been written of the environment of implants, yet the 'milieu interieur' of Claude Bernard (1865) is perhaps the most important aspect of the whole subject. We know that every cell in the body depends on a constant environment for its nutrition and function. Does an implant require the same? Or does the implant alter the local environment ?
Recent Work with Polyhydroxyethylmethacrylate (PolyHEMA: Hydron) PolyHEMA is hydroxyethylmethacrylate crosslinked to form a polymer. When made with over 38 % of water, polyHEMA is precipitated as droplets to form a sponge. The pore size of the sponge can be altered so that the pores are large when 0 5% diester (the cross-linking agent) is used in fabrication, and small when 1 % diester is used. The addition of 4 % methacrylic acid can increase the number of CO radicals and decrease the OH radicals, and can also produce a different tissue response. It can therefore be seen that, if only we can say what we want, the plastic chemist can probably provide it. The large pore sponge (0 5 % diester) provokes a tissue response similar to that from any other spongethe ingrowth of fibrous tissue and blood vessels, and the presence of giant cells which we recognize as undesirable.
In the small pore sponge (1 % diester) no such ingrowth occurs but the material becomes filled with what we strongly suspect is interstitial fluidbut with a difference. The method of collection of interstitial or tissue fluid is described by Calnan, Ford, Holt & Pflug (1970) and a detailed assessment of the properties of polyHEMA is made by Calnan, Pflug & Chhabra (1970) , but I want here to draw attention to the differences in the fluid environment ofthe latter.
Interstitial fluid was sampled from implanted tissue cages (Guyton 1963 ) and compared with samples of fluid from the hollow centre of a shaped polyHEMA sponge.
In 14 greyhounds, the protein-content of poly-HEMA and tissue cage fluid were almost identical, but both differed substantially from that of blood (Table 1 ). The electrolytes in the sample from polyHEMA differ from those of blood only in the chloride content, which is significantly higher in polyHEMA (Table 2) . However, when we com- Table 1 Greyhounds: total proteins (g/100 ml) three months after implantation of tissue cases and polyHEMA forms. Tissue cages in polyHEMA in situ 2i months pare the fluid from tissue cages and polyHEMA we find that the two differ in potassium content, for that in polyHEMA is similar to blood. Tissue fluid contains significantly more chloride and less potassium than blood. The fluid within polyHEMA, however, differs only in the chloride content (Table 3 ) and in this way differs from tissue fluid. In other words, polyHEMA has created a different environment.
We can show that the environment is dynamic and not static by sampling for concentration of, say, an antibiotic given daily. Table 4 shows the comparable build up of nalidixic acid in poly-HEMA compared with tissue fluid. In Table 5 gentamicin behaves in much the same way although here the total proteins in the polyHEMA are only half of the tissue concentration.
